Aveo Pharmaceuticals

AVEO Pharmaceuticals (NASDAQ: AVEO) is a publicly traded cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO was founded in 2002 as GenPath Pharmaceuticals and raised $100M+ in venture funding as a private venture before its $81M IPO in 2010.


Company Profile

Aveo Pharmaceuticals Logo